UBS Maintains a 'Neutral' on MedAssets (MDAS); Another Step in the Right Direction

February 24, 2012 1:49 PM EST
Get Alerts MDAS Hot Sheet
Price: $31.35 --0%

Rating Summary:
    3 Buy, 20 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Neutral' on MedAssets (NASDAQ: MDAS) price target raised from $10 to $14.

UBS analyst says, "MDAS finished 2011 strong with 4Q featuring revenue of $157 mil (UBSe: $152 mil) and EPS a penny above consensus. Both SCM and RCM revenue exceeded Street views. Since the mid 2011 earnings reset and mgmt changes, MDAS has delivered upside in both 3Q and 4Q and in our view, is rebuilding trust with investors."

"...We trimmed our 2012e EPS to $1.06 (was $1.10), but sensed a conservative tone from management on the call."

For an analyst ratings summary and ratings history on MedAssets click here. For more ratings news on MedAssets click here.

Shares of MedAssets closed at $13.60 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

UBS, Earnings